Tema ETFs
NTLA icon

Tema ETFs’s Intellia Therapeutics NTLA Stock Holding History

Tema ETFs’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-13,708
Closed -$232K – 611
2026
Q2 		$232K Sell
13,708
-368
-3% -$5.15K 0.01% 510
2026
Q1 		$180K Sell
14,076
-184
-1% -$2.34K 0.01% 488
2025
Q4 		$128K Sell
14,260
-460
-3% -$6.33K 0.01% 520
2025
Q3 		$254K Sell
14,720
-9,333
-39% -$115K 0.02% 487
2025
Q2 		$226K Sell
24,053
-2,484
-9% -$20.4K 0.06% 161
2025
Q1 		$189K Sell
26,537
-121,630
-82% -$1.23M 0.06% 141
2024
Q4 		$1.73M Buy
+148,167
New +$2.31M 0.72% 42

Other funds holding NTLA

Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Canal Insurance Company
Canal Insurance Company Greenville, South Carolina $426M AUM 30.47% 1-Year Est. Return
Elmwood Wealth Management
Elmwood Wealth Management Berkeley, California $416M AUM 11.87% 1-Year Est. Return
SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return
Cyndeo Wealth Partners
Cyndeo Wealth Partners St. Petersburg, Florida $2.21B AUM 17.29% 1-Year Est. Return
Axxcess Wealth Management
Axxcess Wealth Management Carlsbad, California $2.44B AUM 16.42% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Tema ETFs's NTLA Position: Q3 2026 in Review

Tema ETFs sold out of Intellia Therapeutics (NTLA) in Q3 2026, closing a stake of 13,708 shares — an estimated $232K sold.

Tema ETFs first reported a position in NTLA in Q4 2024 and held it in 7 quarters. The position peaked at $1.73M in Q4 2024. 45 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.

  • Tema ETFs reported no remaining Intellia Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Tema ETFs sold 13,708 Intellia Therapeutics shares in Q3 2026, an estimated $232K.
  • Tema ETFs first reported a position in Intellia Therapeutics in Q4 2024 and held it in 7 quarters.
  • Tema ETFs's Intellia Therapeutics position peaked at $1.73M in Q4 2024.
  • 45 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.